AU2003258690A8 - Method for the identification of proteins specific for renal cell carcinoma and use thereof - Google Patents

Method for the identification of proteins specific for renal cell carcinoma and use thereof

Info

Publication number
AU2003258690A8
AU2003258690A8 AU2003258690A AU2003258690A AU2003258690A8 AU 2003258690 A8 AU2003258690 A8 AU 2003258690A8 AU 2003258690 A AU2003258690 A AU 2003258690A AU 2003258690 A AU2003258690 A AU 2003258690A AU 2003258690 A8 AU2003258690 A8 AU 2003258690A8
Authority
AU
Australia
Prior art keywords
identification
cell carcinoma
renal cell
proteins specific
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003258690A
Other versions
AU2003258690A1 (en
Inventor
Alois Harder
Bernd Muhlenweg
Thomas Halder
Michael Kersten
Barbara Seliger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heidelberg Pharma AG
Original Assignee
Wilex AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wilex AG filed Critical Wilex AG
Publication of AU2003258690A1 publication Critical patent/AU2003258690A1/en
Publication of AU2003258690A8 publication Critical patent/AU2003258690A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003258690A 2002-08-30 2003-08-29 Method for the identification of proteins specific for renal cell carcinoma and use thereof Abandoned AU2003258690A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10240118.7 2002-08-30
DE2002140118 DE10240118A1 (en) 2002-08-30 2002-08-30 Characterizing and identifying proteins specific for renal cell carcinoma, useful for diagnosis, prognosis, prevention and treatment, comprises comparing proteome patterns of healthy and diseased tissue
PCT/EP2003/009637 WO2004025302A2 (en) 2002-08-30 2003-08-29 Method for the identification of proteins specific for renal cell carcinoma and use thereof

Publications (2)

Publication Number Publication Date
AU2003258690A1 AU2003258690A1 (en) 2004-04-30
AU2003258690A8 true AU2003258690A8 (en) 2004-04-30

Family

ID=31502175

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003258690A Abandoned AU2003258690A1 (en) 2002-08-30 2003-08-29 Method for the identification of proteins specific for renal cell carcinoma and use thereof

Country Status (3)

Country Link
AU (1) AU2003258690A1 (en)
DE (1) DE10240118A1 (en)
WO (1) WO2004025302A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014128258A1 (en) 2013-02-22 2014-08-28 Wilex Ag Caix stratification based cancer treatment
US20170168055A1 (en) * 2015-12-11 2017-06-15 Expression Pathology, Inc. SRM/MRM Assays

Also Published As

Publication number Publication date
AU2003258690A1 (en) 2004-04-30
WO2004025302A2 (en) 2004-03-25
DE10240118A1 (en) 2004-03-11
WO2004025302A3 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
EP1551447A4 (en) Anti-addl antibodies and uses thereof
PT2368907T (en) Anti-abeta antibodies and their use
EP1660638A4 (en) Lipoparticles comprising proteins, methods of making, and using the same
PL349132A1 (en) Method and kit for extracting prion protein
EP1588298A4 (en) Capacity planning method and system
IL166467A0 (en) Auto-stimulating cells and method for making and using the same
EP1576088A4 (en) Dominant negative proteins and methods thereof
GB2394581B (en) Register file and design method for the same
GB0209884D0 (en) Proteins
IL163845A0 (en) Method and system for the automaticplanning of experiments
IL138946A0 (en) Method for the identification of peptides and proteins
KR100532144B9 (en) Map information providing system and method thereof
SG111281A1 (en) Nondestructive and noncontact analysis system
AU2003273841A8 (en) Method for identifying bhs-specific proteins and fragments thereof
AU2003207628A8 (en) Structural and cytoskeleton-associated proteins
AU2003258690A8 (en) Method for the identification of proteins specific for renal cell carcinoma and use thereof
EP1487874A4 (en) Falp proteins
IL163751A0 (en) Method for the detection of proteins of animal origin in complex mixtures
AU2003209735A1 (en) Filament-recruiting fluorescent proteins for the analysis and identification of protein-protein-interactions
EP1563073A4 (en) Protein production methods and modified cells for use therein
EP1541677A4 (en) Novel proteins and use thereof
AU2003236174A1 (en) In situ nucleic acid chip and the preparation method thereof
AU2003225036A8 (en) Cancer-associated nucleic acids and polypeptides
GB0223860D0 (en) Polypeptide methods and means
EP1549951A4 (en) Semaphorin-like proteins and methods of using same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase